| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |